Literature DB >> 180525

Poliovirus-induced inhibition of polypeptide initiation in vitro on native polyribosomes.

Y Kaufmann, E Goldstein, S Penman.   

Abstract

The inhibition of HeLa cell protein synthesis by poliovirus was studied by examining initiation in vitro on endogenous host polyribosomes. At an early stage, before major viral RNA replication and protein synthesis begins, the initiation of translation on cellular mRNA is strongly inhibited. Fractionation of extracts from infected cells shows that the lesion is associated mainly with the crude polyribosome fraction. The cellular mRNA appears unchanged and is as active as mRNA from control cells in stimulating incorporation. The native ribosomal subunits and KCl-washed polyribosomes from the infected cells are also active. Only the ribosomal wash fraction prepared from the inhibited polyribosomes had reduced activity. However, the reduction in the ribosomal wash activity measured in a reconstructed system is not as large as the inhibition seen with "native" polyribosomes. The results indicate that a viral induced inhibition is probably associated with the ribosomal wash fraction, but the reconstructed system is not equivalent to the "native" inhibited system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180525      PMCID: PMC430401          DOI: 10.1073/pnas.73.6.1834

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  A CYTOPLASMIC STRUCTURE INVOLVED IN THE SYNTHESIS AND ASSEMBLY OF POLIOVIRUS COMPONENTS.

Authors:  S PENMAN; Y BECKER; J E DARNELL
Journal:  J Mol Biol       Date:  1964-04       Impact factor: 5.469

2.  SPECIFIC INHIBITION OF REPLICATION OF ANIMAL VIRUSES.

Authors:  I TAMM; H J EGGERS
Journal:  Science       Date:  1963-10-04       Impact factor: 47.728

3.  STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. I. THE RELATION BETWEEN POLIOVIRUS,-INDUCED METABOLIC AND MORPHOLOGICAL ALTERATIONS IN CULTURED CELLS.

Authors:  R BABLANIAN; H J EGGERS; I TAMM
Journal:  Virology       Date:  1965-05       Impact factor: 3.616

4.  Nonribosomal proteins associated with eukaryotic native small ribosomal subunits.

Authors:  C Freienstein; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

5.  Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates.

Authors:  E Ehrenfeld; T Hunt
Journal:  Proc Natl Acad Sci U S A       Date:  1971-05       Impact factor: 11.205

6.  Initiation of polyribosome formation in poliovirus-infected HeLa cells.

Authors:  A S Huang; D Balitmore
Journal:  J Mol Biol       Date:  1970-02-14       Impact factor: 5.469

7.  Disaggregation of HeLa cell polysomes after infection with poliovirus.

Authors:  D F Summers; J V Maizel
Journal:  Virology       Date:  1967-03       Impact factor: 3.616

8.  The metabolism of a poly(A) minus mRNA fraction in HeLa cells.

Authors:  C Milcarek; R Price; S Penman
Journal:  Cell       Date:  1974-09       Impact factor: 41.582

9.  The regulation of protein synthesis in mammalian cells VI. Soluble and polyribosome associated components in controlling in vitro polypeptide initiation in HeLa cells.

Authors:  E S Goldstein; M E Reichman; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Effects on host cell metabolism following synchronous infection with poliovirus.

Authors:  S Penman; D Summers
Journal:  Virology       Date:  1965-12       Impact factor: 3.616

View more
  28 in total

1.  The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer.

Authors:  V Evdokimova; P Ruzanov; H Imataka; B Raught; Y Svitkin; L P Ovchinnikov; N Sonenberg
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

2.  Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity.

Authors:  E E Wyckoff; R E Lloyd; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  A convenient sequencing method for 5' protein-linked RNAs.

Authors:  A Nomoto; N Imura
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

4.  Two initiation sites for translation of poliovirus RNA in vitro: comparison of LSc and Mahoney strains.

Authors:  H Jense; F Knauert; E Ehrenfeld
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

5.  Inhibition of translation by poliovirus: inactivation of a specific initiation factor.

Authors:  J K Rose; H Trachsel; K Leong; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Rapamycin stimulates viral protein synthesis and augments the shutoff of host protein synthesis upon picornavirus infection.

Authors:  L Beretta; Y V Svitkin; N Sonenberg
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Inhibition of translation in cells infected with a poliovirus 2Apro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2.

Authors:  R E O'Neill; V R Racaniello
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Shutoff of neuroblastoma cell protein synthesis by Semliki Forest virus: loss of ability of crude initiation factors to recognize early Semliki Forest virus and host mRNA's.

Authors:  H van Steeg; A Thomas; S Verbeek; M Kasperaitis; H O Voorma; R Benne
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

9.  Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus.

Authors:  A C Gingras; Y Svitkin; G J Belsham; A Pause; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

10.  Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells.

Authors:  D Etchison; J Hansen; E Ehrenfeld; I Edery; N Sonenberg; S Milburn; J W Hershey
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.